Antidrug Antibodies to Tumor Necrosis Factor &#945; Inhibitors in Patients With Noninfectious Uveitis.

Bellur, Sunil; McHarg, Matthew; Kongwattananon, Wijak; Vitale, Susan; Sen, H Nida; Kodati, Shilpa

Antidrug Antibodies to Tumor Necrosis Factor α Inhibitors in Patients With Noninfectious Uveitis.

Bellur, Sunil; McHarg, Matthew; Kongwattananon, Wijak; Vitale, Susan; Sen, H Nida; Kodati, Shilpa.

Afiliación

Bellur S; National Eye Institute, National Institutes of Health, Bethesda, Maryland.
McHarg M; National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Kongwattananon W; George Washington University School of Medicine and Health Sciences, Washington, DC.
Vitale S; National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Sen HN; Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Kodati S; National Eye Institute, National Institutes of Health, Bethesda, Maryland.

JAMA Ophthalmol ; 141(2): 150-156, 2023 02 01.

Article en En | MEDLINE | ID: mdl-36547953

Asunto(s)

Factor de Necrosis Tumoral alfa; Uveítis; Humanos; Masculino; Femenino; Adulto; Infliximab/uso terapéutico; Adalimumab/uso terapéutico; Estudios Retrospectivos; Monitoreo de Drogas; Estudios Transversales; Anticuerpos/sangre; Anticuerpos/inmunología; Factores Inmunológicos/uso terapéutico; Inmunosupresores; Uveítis/diagnóstico; Uveítis/tratamiento farmacológico; Antimetabolitos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis / Factor de Necrosis Tumoral alfa Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Ophthalmol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google